1. Home
  2. VEL vs CYRX Comparison

VEL vs CYRX Comparison

Compare VEL & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Velocity Financial Inc.

VEL

Velocity Financial Inc.

N/A

Current Price

$16.30

Market Cap

765.5M

Sector

Finance

ML Signal

N/A

Logo CryoPort Inc.

CYRX

CryoPort Inc.

N/A

Current Price

$16.12

Market Cap

883.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VEL
CYRX
Founded
2004
1999
Country
United States
United States
Employees
N/A
1100
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
765.5M
883.3M
IPO Year
2019
2008

Fundamental Metrics

Financial Performance
Metric
VEL
CYRX
Price
$16.30
$16.12
Analyst Decision
Hold
Strong Buy
Analyst Count
3
9
Target Price
★ $20.83
$19.78
AVG Volume (30 Days)
153.2K
★ 730.0K
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
43.98
★ 156.22
EPS
★ 1.21
N/A
Revenue
N/A
★ $176,177,000.00
Revenue This Year
N/A
$10.95
Revenue Next Year
$17.51
$10.11
P/E Ratio
$13.07
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$14.18
$7.61
52 Week High
$21.40
$18.88

Technical Indicators

Market Signals
Indicator
VEL
CYRX
Relative Strength Index (RSI) 65.53 40.41
Support Level $14.22 $16.13
Resistance Level $19.03 $16.87
Average True Range (ATR) 0.50 0.80
MACD 0.24 -0.11
Stochastic Oscillator 96.47 5.06

Price Performance

Historical Comparison
VEL
CYRX

About VEL Velocity Financial Inc.

Velocity Financial Inc is a United States-based real estate finance company. Company operates in a large fragmented market with substantial demand for financing and limited supply of institutional financing alternative The company originates and manages investor loans secured by residential rental and small commercial properties. The company earns revenue in the form of interest income. It operates in New York, California, Florida, New Jersey, and other states.

About CYRX CryoPort Inc.

CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.

Share on Social Networks: